Go Pro
LON:APH

Alliance Pharma (APH) Share Price, News & Analysis

Alliance Pharma logo

About Alliance Pharma Stock (LON:APH)

Key Stats

Today's Range
N/A
50-Day Range
64.70
64.70
52-Week Range
N/A
Volume
N/A
Average Volume
5.95 million shs
Market Capitalization
£350.32 million
P/E Ratio
N/A
Dividend Yield
3.75%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics. It provides its products under the Aloclair, Anbesol, Asthon and Parsons, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. Alliance Pharma plc was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom.

Receive APH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alliance Pharma and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

APH Stock News Headlines

RBC Capital Reaffirms Their Hold Rating on Alliance Pharma (APH)
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.tc pixel
Alliance Pharma Regulatory News
See More Headlines

APH Stock Analysis - Frequently Asked Questions

Alliance Pharma plc (LON:APH) issued its quarterly earnings data on Tuesday, April, 8th. The company reported $4.32 EPS for the quarter. Alliance Pharma had a negative trailing twelve-month return on equity of 5.04% and a negative net margin of 6.00%.

Shares of APH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alliance Pharma investors own include boohoo group (BOO), BP (BP), Vodafone Group Public (VOD), Aviva (AV), Babcock International Group (BAB), BAE Systems (BA) and The Gym Group (GYM).

Company Calendar

Last Earnings
4/08/2025
Today
8/23/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
LON:APH
CIK
N/A
Fax
N/A
Employees
91,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (6.20)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
1.04
Net Income
-£33.65 million
Net Margins
-6.00%
Pretax Margin
N/A
Return on Equity
-5.04%
Return on Assets
5.98%

Debt

Debt-to-Equity Ratio
46.09
Current Ratio
2.84
Quick Ratio
1.42

Sales & Book Value

Annual Sales
£183.50 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
7.87
Book Value
GBX 41.25 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
541,444,969
Free Float
N/A
Market Cap
£350.32 million
Optionable
Not Optionable
Beta
0.67
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (LON:APH) was last updated on 8/23/2026 by MarketBeat.com Staff.
From Our Partners